Carl Shapiro is a dicussant during the session titled “An Aggregative Games Approach to Merger Analysis in Multiproduct-Firm Oligopoly.”
For more information on this event, click here.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
